Gino Santini - 28 Apr 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Apr 2023
Net transactions value
$0
Form type
4
Filing time
02 May 2023, 19:36:55 UTC
Previous filing
27 May 2022
Next filing
19 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +3,913 +7.3% 57,867 28 Apr 2023 Direct F1, F2
holding HZNP Ordinary Shares 18,655 28 Apr 2023 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Options Exercise $0 -3,913 -100% $0.000000* 0 28 Apr 2023 Ordinary Shares 3,913 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2 30,159 Ordinary Shares previously reported as held indirectly by Trust held directly.